Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STELLA: PletaalO (cilostazol) in vasospastic angina
KCT0000212Phase 2Completed
- Sponsor
- Korea Otsuka Pharmaceutical
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cilostazol in Coronary vasospasm (CAS), sponsored by Korea Otsuka Pharmaceutical. Started Oct 2011; status: completed.
02
Drugs
cilostazol
03
Conditions
Coronary vasospasm (CAS)
Beyond the preview
Go deeper on KCT0000212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000212.